Why Is Cancer More Common in Men Than in Women?

The molecular processes that lead males to be more susceptible to the disease are only beginning to come to light.

Written byJef Akst
| 4 min read
cancer more common in men

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: Glioblastoma, a brain cancer, is much more common in men than in women. WIKIMEDIA COMMONS, NEPHRON

More than half of neurooncologist Josh Rubin’s pediatric brain cancer patients over his 25-year career have been boys. Rubin’s colleagues, first at the Dana-Farber Cancer Institute in Boston and for the past 16 years at Washington University School of Medicine in St. Louis, noticed a similar male bias in adults with the cancer. About a decade ago, curious if his and his colleagues’ experiences were backed by data, Rubin turned to national registries for cancer incidence and outcome. The data revealed that, “indeed, for decades it’s been documented that . . . overall, males get more cancer than females,” he says.

Prognosis and survival were also typically worse in men than in women across a range of cancers, Rubin learned. Beyond those cancers for which anatomy dictates they be predominantly or exclusively female—breast, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile

Published In

The Scientist April 2019 Issue
April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies